Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	GAIN_dom_N	CELSR2 ADGRL2 ADGRL3	1.06e-04	11	165	3	IPR032471
Domain	GAIN	CELSR2 ADGRL2 ADGRL3	1.06e-04	11	165	3	PF16489
Domain	OLF	OLFM4 ADGRL2 ADGRL3	1.81e-04	13	165	3	PF02191
Domain	OLF	OLFM4 ADGRL2 ADGRL3	1.81e-04	13	165	3	PS51132
Domain	Olfac-like_dom	OLFM4 ADGRL2 ADGRL3	1.81e-04	13	165	3	IPR003112
Domain	OLF	OLFM4 ADGRL2 ADGRL3	1.81e-04	13	165	3	SM00284
Domain	Latrophilin	ADGRL2 ADGRL3	2.31e-04	3	165	2	PF02354
Domain	GPCR_2_latrophilin_rcpt_C	ADGRL2 ADGRL3	2.31e-04	3	165	2	IPR003334
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	PDE3B TTC28 MYO6 TAB2 FAM171B SVIL SEC16A TNRC6A HELZ PARD3 UTRN FAM135A GOLGB1	7.87e-10	263	172	13	34702444
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	TDRD15 EP400 TTC28 MYO6 FAM171B BIRC6 CDC42EP1 LRIG2 PPP2R3A PPP1R15B SEC16A TNRC6A DCLRE1A HCFC2 PARD3 ADGRL2 FAM135A NUP160 HSPA9 GOLGB1	2.10e-09	777	172	20	35844135
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KNTC1 MYO6 CEP290 BIRC6 ZNF462 LRIG2 CCDC88C USF3 AARS2 SACS TTC9 CDC5L FAM135A NUP160 DOP1A KIF1C	3.76e-09	493	172	16	15368895
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	KNTC1 EP400 TTC28 CEP290 FNDC3A BIRC6 TDRD3 YAP1 SEC16A TNRC6A HELZ DCLRE1A CEP295 QSER1 CDC5L PPIP5K2 ESPL1 KNL1	2.88e-08	733	172	18	34672954
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	KNTC1 TTC28 BIRC6 CDC42EP1 CCDC88C YAP1 SEC16A TNRC6A HELZ CEP295 PARD3 UTRN NUP160 KIF1C	5.57e-08	446	172	14	24255178
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TET2 EP400 LMTK2 FNDC3A CWC22 HECW2 TNRC6A ANKIB1 IPO13 PLAGL2 PPIP5K2 ADGRL2 KAT6B ESPL1 RAI1	6.93e-08	529	172	15	14621295
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SPAM1 ZNF148 EP400 TTC28 ATAD5 FAT3 CHD9 CDC42EP1 SEC16A TNRC6A AHR SFXN2 TEKT1 HELZ CEP295 PARD3 ADGRL2 KAT6B RAI1 ALPL KNL1	1.75e-07	1116	172	21	31753913
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	COQ5 FAM171B CDC42EP1 ZDHHC20 APPL2 CELSR2 SEC16A SEMA6A PARD3 ADGRL2 UTRN FAM135A GOLGB1	2.04e-07	421	172	13	36976175
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	CAD ATAD5 CEP290 LMTK2 TAB2 PTPN22 FAM171B BIRC6 PTPRT CDC42EP1 TDRD3 PPP2R3A SVIL SEC16A TNRC6A HELZ CDC5L ADGRL2 UTRN KNL1	2.86e-07	1049	172	20	27880917
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TET2 PDE3B TTC28 LMTK2 TAB2 CDC42EP1 CCDC88C BMPR2 YAP1 SVIL SEC16A HELZ PPIP5K2 PARD3 UTRN GOLGB1 DOP1A KIF1C	3.12e-07	861	172	18	36931259
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TET2 ZNF148 ZNF280D TTC28 RFX1 BIRC6 ZNF462 SEC16A TNRC6A UTRN GOLGB1 KNL1	1.30e-06	418	172	12	34709266
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	KNTC1 CAD EP400 TTC28 TAB2 TDRD3 YAP1 SEC16A TNRC6A HELZ CFAP44 FAM135A GOLGB1 KNL1	1.53e-06	588	172	14	38580884
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	TTC28 FNDC3A TAB2 MED13L BIRC6 ZNF462 SEC16A CDC5L KAT6B	1.99e-06	225	172	9	12168954
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TET2 KNTC1 CAD ZNF148 EP400 CHD9 PTPN22 COPS3 MED13L RFX1 CELF1 CELF2 TKT CCAR1 PLAGL2 QSER1 HSPA9 RAI1 KNL1	2.58e-06	1103	172	19	34189442
Pubmed	Heterogeneous murine peribiliary glands orchestrate compartmentalized epithelial renewal.	OLFM4 LGR5 PROM1	4.10e-06	7	172	3	37909044
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	CRYBG2 ZNF148 EP400 TTC28 CEP290 BIRC6 ZNF462 CELF1 TNRC6A CCAR1 CDC5L NUP160	4.25e-06	469	172	12	27634302
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TRPM4 CRYBG2 EP400 NTSR1 LMTK2 GRID1 MED13L BIRC6 CCDC88C TDRD3 CELSR2 PIK3CD PPP1R15B SLC35A2 SEC16A ESPL1 SOWAHB RAI1	1.03e-05	1105	172	18	35748872
Pubmed	Proteomic analysis of FOXP proteins reveals interactions between cortical transcription factors associated with neurodevelopmental disorders.	BNC2 ZNF148 RFX1 CDC5L	1.08e-05	28	172	4	29365100
Pubmed	A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.	ZNF410 ZNF148 TTC28 MED13L LGR5 BIRC6 PPP2R3A NEK5 TKT HELZ RAI1	1.10e-05	431	172	11	33660365
Pubmed	Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	TAB2 LRIG2 SACS IPO13 ADGRL2 ADGRL3	1.15e-05	101	172	6	9872452
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	AARS2 TKT SVIL SEC16A CCAR1 CDC5L PPIP5K2 UTRN HSPA9 GOLGB1	1.35e-05	360	172	10	33111431
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	MYO6 CEP290 CHD9 SEC16A KAT6B DNAH9	1.36e-05	104	172	6	9205841
Pubmed	Primary cilium migration depends on G-protein signalling control of subapical cytoskeleton.	MYO6 GNAI3 PARD3	1.39e-05	10	172	3	23934215
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	ZNF148 ZNF484 LMTK3 SPATA31D4 SPATA31D3 AARS2 ANKIB1 CEP295	2.26e-05	233	172	8	37704626
Pubmed	HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP.	CWC22 MYO3A UTRN GOLGB1	2.39e-05	34	172	4	25925205
Pubmed	LGR5 promotes invasion and migration by regulating YAP activity in hypopharyngeal squamous cell carcinoma cells under inflammatory condition.	LGR5 YAP1	2.43e-05	2	172	2	36288272
Pubmed	Latrophilin GPCRs direct synapse specificity by coincident binding of FLRTs and teneurins.	ADGRL2 ADGRL3	2.43e-05	2	172	2	30792275
Pubmed	Isolation and expression of Napor/CUG-BP2 in embryo development.	CELF1 CELF2	2.43e-05	2	172	2	12763013
Pubmed	Expression of a dominant negative CELF protein in vivo leads to altered muscle organization, fiber size, and subtype.	CELF1 CELF2	2.43e-05	2	172	2	21541285
Pubmed	Latrophilin GPCR signaling mediates synapse formation.	ADGRL2 ADGRL3	2.43e-05	2	172	2	33646123
Pubmed	Loss of aryl hydrocarbon receptor suppresses the response of colonic epithelial cells to IL22 signaling by upregulating SOCS3.	LGR5 AHR	2.43e-05	2	172	2	34755534
Pubmed	CC2D2A is mutated in Joubert syndrome and interacts with the ciliopathy-associated basal body protein CEP290.	CEP290 CC2D2A	2.43e-05	2	172	2	18950740
Pubmed	LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.	LGR5 PROM1	2.43e-05	2	172	2	27435662
Pubmed	Diversity and conservation of CELF1 and CELF2 RNA and protein expression patterns during embryonic development.	CELF1 CELF2	2.43e-05	2	172	2	23468433
Pubmed	Immunohistochemical Expression of CD133 and LGR5 in Ulcerative Colitis-associated Colorectal Cancer and Dysplasia.	LGR5 PROM1	2.43e-05	2	172	2	31280219
Pubmed	Identification of potential bladder progenitor cells in the trigone.	LGR5 PROM1 TACSTD2	2.53e-05	12	172	3	24992712
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CAD LMTK3 ZNF462 LRIG2 CCDC88C TDRD3 CELSR2 SVIL SEC16A CCAR1 QSER1 CDC5L PARD3 HSPA9 GOLGB1 RAI1	2.57e-05	963	172	16	28671696
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	SPAG1 EPS8L2 MYO6 FAM171B CDC42EP1 BMPR2 YAP1 SVIL PARD3 ADGRL2 UTRN GOLGB1	2.71e-05	565	172	12	25468996
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	LGMN LMTK2 TAB2 FAM171B SPATA1 CELF1 PIK3CD SEC16A CEP295 GNAI3 QSER1 PARD3 ESPL1 UTRN FAM135A ARHGEF6 GOLGB1	2.95e-05	1084	172	17	11544199
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	ZNF148 YAP1 SEC16A TNRC6A CCAR1 NUP160 RAI1	3.37e-05	180	172	7	35198878
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ZNF148 EP400 RFX1 MYO3A YAP1 TKT SVIL SEC16A CCAR1 HELZ PARD3 KAT6B ESPL1 ARHGEF6	3.38e-05	774	172	14	15302935
Pubmed	GATA4 and GATA6 regulate intestinal epithelial cytodifferentiation during development.	OLFM4 APOA4 LGR5 ABCG8	4.15e-05	39	172	4	24929016
Pubmed	ZW10 links mitotic checkpoint signaling to the structural kinetochore.	KNTC1 DSN1 KNL1	4.16e-05	14	172	3	15824131
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	PDE3B CAD ZNF148 MYO6 ATAD5 COQ5 FNDC3A CDC42EP1 LRIG2 SACS PPP1R15B SEMA6A CDC5L TMEM231 PARD3 ADGRL2 ESPL1 FAM135A HSPA9 GOLGB1	5.04e-05	1487	172	20	33957083
Pubmed	Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1.	KNTC1 PLAGL2 ESPL1 NUP160	5.07e-05	41	172	4	8724849
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TRPM4 PDE3B EOGT MYO6 CHD9 ZNF462 BMPR2 PPP2R3A USF3 ANKIB1 CCAR1 SEMA6A QSER1 PARD3 KAT6B METTL15 UTRN GOLGB1 RAI1 DOP1A	5.13e-05	1489	172	20	28611215
Pubmed	Id2 controls specification of Lgr5+ intestinal stem cell progenitors during gut development.	LGR5 PROM1 TACSTD2	5.18e-05	15	172	3	28077488
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	LGMN CAD MYO6 ACP2 COPS3 CREG1 TFR2 LRIG2 TKT TMEM231 HSPA9 ALPL	5.92e-05	613	172	12	22268729
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	TET2 ZNF148 EP400 MED13L YAP1 QSER1 RAI1 KNL1	6.07e-05	268	172	8	33640491
Pubmed	A family of heptahelical receptors with adhesion-like domains: a marriage between two super families.	ADGRL2 ADGRL3	7.27e-05	3	172	2	10994649
Pubmed	AHR/TET2/NT5E axis downregulation is associated with the risk of systemic lupus erythematosus and its progression.	TET2 AHR	7.27e-05	3	172	2	36314527
Pubmed	Myosin VI and its interacting protein LMTK2 regulate tubule formation and transport to the endocytic recycling compartment.	MYO6 LMTK2	7.27e-05	3	172	2	18029400
Pubmed	YAP, but Not RSPO-LGR4/5, Signaling in Biliary Epithelial Cells Promotes a Ductular Reaction in Response to Liver Injury.	LGR5 YAP1	7.27e-05	3	172	2	31080135
Pubmed	The Environmental Sensor AHR Protects from Inflammatory Damage by Maintaining Intestinal Stem Cell Homeostasis and Barrier Integrity.	LGR5 AHR	7.27e-05	3	172	2	30119997
Pubmed	TET2 promotes IL-1β expression in J774.1 cell through TLR4/MAPK signaling pathway with demethylation of TAB2 promoter.	TET2 TAB2	7.27e-05	3	172	2	32823238
Pubmed	Structural and functional analysis of the apoptosis-associated tyrosine kinase (AATYK) family.	LMTK2 LMTK3	7.27e-05	3	172	2	17651901
Pubmed	Genome Toxicity and Impaired Stem Cell Function after Conditional Activation of CreERT2 in the Intestine.	OLFM4 LGR5	7.27e-05	3	172	2	30449703
Pubmed	The multiple actions of black widow spider toxins and their selective use in neurosecretion studies.	ADGRL2 ADGRL3	7.27e-05	3	172	2	15066411
Pubmed	Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine.	LGR5 PROM1	7.27e-05	3	172	2	19324043
Pubmed	RNA-binding protein CUGBP1 regulates insulin secretion via activation of phosphodiesterase 3B in mice.	PDE3B CELF1	7.27e-05	3	172	2	27255754
Pubmed	LSR targets YAP to modulate intestinal Paneth cell differentiation.	LGR5 YAP1	7.27e-05	3	172	2	37703178
Pubmed	Primary cilia biogenesis and associated retinal ciliopathies.	CEP290 CC2D2A	7.27e-05	3	172	2	32747192
Pubmed	Restriction of intestinal stem cell expansion and the regenerative response by YAP.	LGR5 YAP1	7.27e-05	3	172	2	23178811
Pubmed	alpha-Latrotoxin and its receptors: neurexins and CIRL/latrophilins.	ADGRL2 ADGRL3	7.27e-05	3	172	2	11520923
Pubmed	Wnts regulate planar cell polarity via heterotrimeric G protein and PI3K signaling.	CCDC88C GNAI3 PARD3	7.68e-05	17	172	3	32805026
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	TET2 BNC2 MED13L ZNF462 TDRD3 CELF1 SVIL TNRC6A PPIP5K2 PARD3 KAT6B	7.98e-05	536	172	11	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	TET2 BNC2 MED13L ZNF462 TDRD3 CELF1 SVIL TNRC6A PPIP5K2 PARD3 KAT6B	8.25e-05	538	172	11	10512203
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	EP400 CHD9 COPS3 RFX1 ZNF462 SEC16A QSER1 KNL1	8.66e-05	282	172	8	23667531
Pubmed	Daple coordinates organ-wide and cell-intrinsic polarity to pattern inner-ear hair bundles.	CCDC88C GNAI3 PARD3	9.18e-05	18	172	3	29229865
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	ZNF148 EP400 ATAD5 MED13L RFX1 DSN1 CDC42EP1 DCLRE1A UPP1 KNL1	9.34e-05	453	172	10	29656893
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	FNDC3A COPS3 SEC16A TNRC6A HELZ QSER1 NUP160 HSPA9 GOLGB1 RAI1	1.00e-04	457	172	10	32344865
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	SPAG1 CEP290 COPS3 RFX1 IFT88 NEK5 YAP1 SEC16A IPO13 HELZ QSER1 TBR1 PPIP5K2 TMEM231 PARD3 NUP160 ARHGEF6 KIF1C	1.04e-04	1321	172	18	27173435
Pubmed	MARCKS modulates radial progenitor placement, proliferation and organization in the developing cerebral cortex.	PROM1 TBR1 PARD3	1.09e-04	19	172	3	19666823
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	KNTC1 CAD PCBP3 EP400 CEP290 IFT88 SEC16A CCAR1 CC2D2A HSPA9 GOLGB1	1.25e-04	564	172	11	21565611
Pubmed	Interaction of LATS1 with SMAC links the MST2/Hippo pathway with apoptosis in an IAP-dependent manner.	TET2 CAD BIRC6 YAP1 SVIL CCAR1 IPO13	1.26e-04	222	172	7	35941108
Pubmed	Cell Metabolic Alterations due to Mcph1 Mutation in Microcephaly.	TBR1 PARD3 HSPA9	1.27e-04	20	172	3	32294449
Pubmed	The role of α-E-catenin in cerebral cortex development: radial glia specific effect on neuronal migration.	PROM1 TBR1 PARD3	1.27e-04	20	172	3	25147501
Pubmed	Crumbs 2 prevents cortical abnormalities in mouse dorsal telencephalon.	PROM1 TBR1 PARD3	1.27e-04	20	172	3	26802325
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	TRPM4 SPAG1 CDC42EP1 PROM1 ZDHHC20 CELSR2 SLC35A2 SEMA6A PARD3 TACSTD2 FAM135A	1.35e-04	569	172	11	30639242
Pubmed	Global genetic analysis in mice unveils central role for cilia in congenital heart disease.	CEP290 BMPR2 IFT88 CC2D2A SEMA6A	1.44e-04	100	172	5	25807483
Pubmed	NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivo.	LGR5 YAP1	1.45e-04	4	172	2	38579685
Pubmed	The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability.	LGR5 YAP1	1.45e-04	4	172	2	33932349
Pubmed	BREK/LMTK2 is a myosin VI-binding protein involved in endosomal membrane trafficking.	MYO6 LMTK2	1.45e-04	4	172	2	18429820
Pubmed	MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells.	LGR5 PROM1	1.45e-04	4	172	2	23619912
Pubmed	Intestinal stem cells contribute to the maturation of the neonatal small intestine and colon independently of digestive activity.	SI LGR5	1.45e-04	4	172	2	28860595
Pubmed	The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms.	CELSR2 ADGRL3	1.45e-04	4	172	2	37224017
Pubmed	Degradation of the Separase-cleaved Rec8, a Meiotic Cohesin Subunit, by the N-end Rule Pathway.	ESPL1 ALPL	1.45e-04	4	172	2	26858254
Pubmed	A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors.	LGR5 PROM1	1.45e-04	4	172	2	21436631
Pubmed	IFNγ-Stat1 axis drives aging-associated loss of intestinal tissue homeostasis and regeneration.	OLFM4 LGR5	1.45e-04	4	172	2	37777550
Pubmed	Latrophilin-2 and latrophilin-3 are redundantly essential for parallel-fiber synapse function in cerebellum.	ADGRL2 ADGRL3	1.45e-04	4	172	2	32202499
Pubmed	LSD1 represses a neonatal/reparative gene program in adult intestinal epithelium.	LGR5 YAP1	1.45e-04	4	172	2	32917713
Pubmed	Loss of aryl hydrocarbon receptor potentiates FoxM1 signaling to enhance self-renewal of colonic stem and progenitor cells.	LGR5 AHR	1.45e-04	4	172	2	32915464
Pubmed	Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.	MICAL1 SEMA6A	1.45e-04	4	172	2	25576923
Pubmed	Yap1-Driven Intestinal Repair Is Controlled by Group 3 Innate Lymphoid Cells.	LGR5 YAP1	1.45e-04	4	172	2	31914395
Pubmed	High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface.	TET2 SIGLEC15 CDC42EP1 ZDHHC20 CELSR2 SEC16A TNRC6A ADGRL2	1.55e-04	307	172	8	37499664
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	EP400 ATAD5 CHD9 WDR76 CELF1 TKT CDC5L UTRN RAI1	1.63e-04	394	172	9	27248496
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	MTIF3 PDE3B CAD TTC28 MYO6 COQ5 FNDC3A BIRC6 FBXL4 TDRD3 AARS2 NDUFAF7 PPP1R15B SEC16A ESPL1 METTL15 NUP160 HSPA9 GOLGB1	1.65e-04	1496	172	19	32877691
Pubmed	A human MAP kinase interactome.	PNLIP MYO6 CEP290 CDC42EP1 PROM1 USF3 KIAA1549L TNRC6A HELZ GOLGB1	1.65e-04	486	172	10	20936779
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	GPR155 EPS8L2 GALM MYO6 ACP2 OLFM4 GRID1 PROM1 FCGBP APPL2 TKT TMPRSS11D GNAI3 UTRN ALPL	1.71e-04	1016	172	15	19056867
Pubmed	Orphan Gpr182 suppresses ERK-mediated intestinal proliferation during regeneration and adenoma formation.	OLFM4 LGR5 YAP1	1.71e-04	22	172	3	28094771
Interaction	FBXO42 interactions	CAD EP400 TTC28 TAB2 COPS3 SEC16A TNRC6A HELZ CFAP44 FAM135A GOLGB1 KNL1	1.66e-06	259	166	12	int:FBXO42
Interaction	RNF43 interactions	PDE3B TTC28 MYO6 TAB2 FAM171B SVIL SEC16A TNRC6A HELZ PARD3 UTRN FAM135A NUP160 HSPA9 GOLGB1	2.64e-06	427	166	15	int:RNF43
GeneFamily	Adhesion G protein-coupled receptors, subfamily L	ADGRL2 ADGRL3	2.26e-04	4	112	2	918
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	SPAG1 TTC28 TMTC1 IFT88 TTC9	7.45e-04	115	112	5	769
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	LMTK2 LMTK3 SACS PPP1R15B PARD3 KNL1	9.22e-04	181	112	6	694
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	ZNF148 CHD9 FNDC3A MED13L SACS AHR HELZ TTC9 PPIP5K2 ADGRL2 KAT6B DOP1A	5.85e-07	300	168	12	M8702
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	TET2 KNTC1 FNDC3A BIRC6 BMPR2 CELSR2 PIK3CD ESPL1 UTRN	2.58e-06	180	168	9	M8239
Coexpression	LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES	TTC28 MED13L TMTC1 BMPR2 HECW2 SVIL ADGRL2 UTRN	2.99e-06	137	168	8	M39241
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	KNTC1 ZNF148 PDGFRL MYO6 CEP290 TDRD3 PPP2R3A CELF2 SACS CCAR1 QSER1 CDC5L PPIP5K2 GOLGB1 KNL1 SPESP1	5.39e-06	656	168	16	M18979
Coexpression	IKEDA_MIR30_TARGETS_UP	BNC2 CHD9 FNDC3A CELF2 TNRC6A ARHGEF6 ADGRL3	1.02e-05	116	168	7	M2379
Coexpression	IKEDA_MIR30_TARGETS_UP	BNC2 CHD9 FNDC3A CELF2 TNRC6A ARHGEF6 ADGRL3	1.08e-05	117	168	7	MM931
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	GPR155 GRID1 MED13L FAM171B LGR5 PTPRT ZNF462 PPP2R3A KIAA1549L CELF1 CELF2 PIK3CD TNRC6A ANKIB1 PAPPA TTC9 HCFC2 ADGRL3 RAI1 DOP1A	2.93e-05	1106	168	20	M39071
Coexpression	GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN	GPR155 TRPM4 PDE3B EPSTI1 PTPN22 CCDC88C PIK3CD UTRN	4.68e-05	200	168	8	M5063
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	TET2 KNTC1 COL12A1 ATAD5 WDR76 DSN1 CELSR2 SFXN2 ESPL1 KNL1	4.74e-05	323	168	10	M2156
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	PDE3B ZNF280D ATAD5 FAT3 CEP290 CHD9 LRRTM3 FAM171B LGR5 ZNF462 CCDC88C PROM1 KIAA1549L CELSR2 PIK3CD CCAR1 DNAI4 PAPPA CEP295 QSER1 SOWAHB KNL1	2.55e-05	1060	165	22	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4	MICAL1 GALM GARNL3 ZNF280D LRRC45 COQ5 LRRTM3 FAM171B ARHGEF25 TDRD3 TMTC1 BMPR2 FBXO24 APPL2 HECW2 AHR IPO13 CC2D2A SEMA6A TMEM231 KAT6B ADGRL3 DOP1A	2.86e-05	1148	165	23	facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000	BNC2 FNDC3A FAM171B TDRD3 TMTC1 CELF2 SVIL PAPPA ADGRL2 ADGRL3	8.87e-05	288	165	10	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	PDE3B ZNF280D ATAD5 FAT3 CEP290 NTSR1 CHD9 LRRTM3 FAM171B LGR5 CWC22 ZNF462 CCDC88C PROM1 KIAA1549L CELSR2 CELF2 PIK3CD CCAR1 DNAI4 PAPPA CEP295 QSER1 SOWAHB KNL1	9.60e-05	1414	165	25	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05	EP400 TTC28 FAT3 CEP290 FAM171B ARHGEF25 LRIG2 CCDC88C CELSR2 CELF2 ART3 IFT88 YAP1 TMEM145 SFXN2 CC2D2A DCLRE1A SEMA6A TMEM231 ADGRL2 KAT6B ADGRL3 ALPL	9.85e-05	1245	165	23	PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	ATAD5 FAT3 CEP290 FAM171B WDR76 CCDC88C PROM1 KIAA1549L CELSR2 CELF2	1.17e-04	298	165	10	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	ZNF280D PDGFRL ATAD5 CEP290 CHD9 FNDC3A ZDHHC20 KIAA1549L NDUFAF7 CCAR1 CEP295 QSER1 FAM135A GOLGB1 KNL1	1.21e-04	629	165	15	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500	ATAD5 FAT3 CEP290 CWC22 CCDC88C PROM1 KIAA1549L CELSR2 CELF2 CCAR1 PAPPA CEP295 KNL1	1.45e-04	498	165	13	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	PTPRT CCDC148 PROM1 LRGUK NEK5 AADACL2 DNAI4 TEKT1 TMEM231 DNAH9	2.35e-09	182	171	10	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PTPRT CCDC148 PROM1 LRGUK NEK5 AADACL2 DNAI4 TEKT1 TMEM231 DNAH9	3.74e-09	191	171	10	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PTPRT CCDC148 PROM1 LRGUK NEK5 AADACL2 DNAI4 TEKT1 TMEM231 DNAH9	3.74e-09	191	171	10	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	PTPRT LRGUK NEK5 YAP1 AADACL2 DNAI4 TEKT1 PARD3 TACSTD2 DNAH9	4.57e-09	195	171	10	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTPRT CCDC148 CCDC88C PROM1 NEK5 DNAI4 TMEM231 CFAP44 DNAH9	1.99e-08	169	171	9	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	PTPRT CCDC148 PROM1 LRGUK NEK5 DNAI4 TEKT1 TMEM231 DNAH9	4.34e-08	185	171	9	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PTPRT CCDC148 PROM1 LRGUK NEK5 AADACL2 DNAI4 TEKT1 DNAH9	5.71e-08	191	171	9	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	renal_papilla_nuclei-Adult_normal_reference\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 GALM FAT3 CHD9 USP9Y TMTC1 FCGBP TACSTD2 UTRN	5.97e-08	192	171	9	6c106b91e46eabbe686a52a65a9c94ad9cbe9390
ToppCell	COPD-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	PTPRT PROM1 LRGUK NEK5 AADACL2 DNAI4 TEKT1 CFAP44 DNAH9	5.97e-08	192	171	9	eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e
ToppCell	IPF-Epithelial-Ciliated\|IPF / Disease state, Lineage and Cell class	PTPRT CCDC148 LRGUK NEK5 AADACL2 DNAI4 TEKT1 CFAP44 DNAH9	5.97e-08	192	171	9	354adc1354bf596fbc60dd45c0169688e6f45165
ToppCell	Bronchial_Brush-Epithelial-Ciliated_1\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	SPAG1 IFT88 NEK5 CC2D2A DNAI4 TEKT1 TMEM231 CFAP44 DNAH9	6.52e-08	194	171	9	b4ce60c06568123008b1081d644733cb91c28f51
ToppCell	Bronchial_Brush-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	SPAG1 IFT88 NEK5 CC2D2A DNAI4 TEKT1 TMEM231 CFAP44 DNAH9	6.52e-08	194	171	9	7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	PTPRT LRGUK NEK5 YAP1 DNAI4 TEKT1 PARD3 TACSTD2 DNAH9	6.81e-08	195	171	9	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	PTPRT LRGUK NEK5 YAP1 DNAI4 TEKT1 PARD3 TACSTD2 DNAH9	6.81e-08	195	171	9	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	COVID-19-Epithelial-Ciliated_cells\|Epithelial / Condition, Lineage and Cell class	SPAG1 PTPRT PROM1 NEK5 DNAI4 TEKT1 TMEM231 CFAP44 DNAH9	7.12e-08	196	171	9	de7aa31354b019d7321a8ef965d59ce2e8b89276
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	PTPRT NEK5 AADACL2 DNAI4 TEKT1 PARD3 CFAP44 TACSTD2 DNAH9	7.12e-08	196	171	9	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPAG1 PROM1 NEK5 CC2D2A DNAI4 TEKT1 TMEM231 CFAP44 DNAH9	7.44e-08	197	171	9	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPAG1 PROM1 DNAI4 TTC9 TMEM231 CFAP44 TACSTD2 DNAH9 GOLGB1	7.77e-08	198	171	9	d0ecace1fad24ce50b0935036fabb07e6c9e372d
ToppCell	saliva-Severe-critical_progression_d28-40-Epithelial\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CRYBG2 SPAG1 EPS8L2 MYO6 YAP1 TMPRSS11D TTC9 PARD3 TACSTD2	8.11e-08	199	171	9	5a1557fe35aa48080d4967e8724bf27f9585a5fb
ToppCell	saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CRYBG2 SPAG1 EPS8L2 MYO6 YAP1 TMPRSS11D TTC9 PARD3 TACSTD2	8.11e-08	199	171	9	0a657475b92aa3a713da62da364525249fdc3886
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3\|TCGA-Cervix / Sample_Type by Project: Shred V9	CRYBG2 TMPRSS11D NIPAL2 TTC9 PARD3 TACSTD2 FAM135A SOWAHB	4.00e-07	175	171	8	0cc215109d9915af47e4d0a120ce2e46910715fa
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FAT3 PTPRT ZNF462 PROM1 SLC44A5 PARD3 UTRN ADGRL3	4.17e-07	176	171	8	327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell	COPD-Endothelial-VE_Venous\|Endothelial / Disease state, Lineage and Cell class	BNC2 ANO2 PNLIP TNFRSF10D TMTC1 BMPR2 UPP1 ALPL	4.75e-07	179	171	8	e816dd846a6918ec143b57a380c3a47ed073b66e
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3B MYO6 CDC42EP1 BMPR2 HECW2 SEMA6A ADGRL2 ADGRL3	4.95e-07	180	171	8	544fb373a3346186ec60afe2cfcf141bb04a1eed
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PTPRT NEK5 CC2D2A DNAI4 TEKT1 TMEM231 CFAP44 DNAH9	6.35e-07	186	171	8	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	Ciliated_cells-B-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	PTPRT PROM1 NEK5 DNAI4 TEKT1 TMEM231 CFAP44 DNAH9	6.61e-07	187	171	8	6fa38dbccca36bc7a4fef46de74c6688f599f421
ToppCell	Control-Epithelial-Ciliated\|Control / Disease state, Lineage and Cell class	PTPRT LRGUK NEK5 AADACL2 DNAI4 TEKT1 CFAP44 DNAH9	7.16e-07	189	171	8	c007fccd08728db3ea99af9da91d67b9b16dabb3
ToppCell	COVID-19-lung-Ciliated\|lung / Disease (COVID-19 only), tissue and cell type	PTPRT CCDC148 PROM1 LRGUK NEK5 DNAI4 TEKT1 DNAH9	7.16e-07	189	171	8	27329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	PTPRT LRGUK NEK5 AADACL2 DNAI4 TEKT1 CFAP44 DNAH9	7.16e-07	189	171	8	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(general)\|COVID-19 / group, cell type (main and fine annotations)	ANO2 TTC28 TMTC1 BMPR2 HECW2 SEMA6A ADGRL2 ADGRL3	7.45e-07	190	171	8	812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FAT3 ZNF462 PROM1 PPP2R3A SLC44A5 DNAI4 PARD3 ADGRL3	7.75e-07	191	171	8	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	Bronchial_Biopsy-Epithelial-Ciliated_1\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	SPAG1 PROM1 NEK5 DNAI4 TEKT1 TMEM231 CFAP44 DNAH9	8.06e-07	192	171	8	be592e661367affced9ebe80849b466e6adb3a34
ToppCell	IPF-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	PTPRT LRGUK NEK5 AADACL2 DNAI4 TEKT1 CFAP44 DNAH9	8.06e-07	192	171	8	d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPAG1 PROM1 NEK5 CC2D2A DNAI4 TEKT1 TMEM231 DNAH9	8.38e-07	193	171	8	e1b76102f812c433195d1e8811fdd3293a7bc22e
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	PTPRT LRGUK NEK5 AADACL2 DNAI4 TEKT1 CFAP44 DNAH9	8.38e-07	193	171	8	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	PTPRT LRGUK IFT88 NEK5 DNAI4 TEKT1 CFAP44 DNAH9	8.38e-07	193	171	8	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	Bronchial_Biopsy-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	SPAG1 PROM1 NEK5 DNAI4 TEKT1 TMEM231 CFAP44 DNAH9	8.38e-07	193	171	8	0b62a6ddd7c42efd9f39781971d1438501e1fa8d
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANO2 TTC28 TMTC1 BMPR2 HECW2 SEMA6A ADGRL2 ADGRL3	8.72e-07	194	171	8	71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3B MYO6 TMTC1 BMPR2 HECW2 SEMA6A ADGRL2 ADGRL3	8.72e-07	194	171	8	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	Control-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	PTPRT LRGUK NEK5 AADACL2 DNAI4 TEKT1 CFAP44 DNAH9	8.72e-07	194	171	8	958e648138676d46698090b4046cb484083ae449
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3B MYO6 TMTC1 BMPR2 HECW2 SEMA6A ADGRL2 ADGRL3	8.72e-07	194	171	8	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPAG1 PTPRT PROM1 NEK5 DNAI4 TEKT1 CFAP44 DNAH9	9.06e-07	195	171	8	9651ee03738226ee10e901f8b9ec6a417eb9c301
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38\|World / Primary Cells by Cluster	TTC28 CHD9 ZNF462 CCDC88C FCGBP CELSR2 SVIL QSER1	9.42e-07	196	171	8	38da0751941adca650fe9b383d9f343153978eb5
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn\|World / Primary Cells by Cluster	TTC28 CHD9 ZNF462 CCDC88C FCGBP CELSR2 SVIL QSER1	9.42e-07	196	171	8	721650a08d260faf530dbd52d4e9275d27f3bac2
ToppCell	COVID-19-lung-Capillary_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANO2 PDE3B TTC28 TMTC1 BMPR2 HECW2 SEMA6A ADGRL2	9.42e-07	196	171	8	ac28e9be288af6f00a841aea4ce4b99aed6b4505
ToppCell	NS-moderate-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SPAG1 PROM1 CC2D2A DNAI4 TEKT1 TMEM231 CFAP44 DNAH9	9.78e-07	197	171	8	71fea4aa6ce96c7693fa94792d08770622873850
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPAG1 PROM1 NEK5 DNAI4 TEKT1 TMEM231 CFAP44 DNAH9	9.78e-07	197	171	8	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPAG1 PROM1 NEK5 DNAI4 TEKT1 TMEM231 CFAP44 DNAH9	9.78e-07	197	171	8	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	control-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PROM1 IFT88 CC2D2A DNAI4 TEKT1 TMEM231 CFAP44 DNAH9	9.78e-07	197	171	8	e453d085182364ca347cbcc9dc995c62c3353016
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPAG1 PROM1 NEK5 DNAI4 TEKT1 TMEM231 CFAP44 DNAH9	9.78e-07	197	171	8	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	control-Epithelial-Ciliated\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PROM1 IFT88 CC2D2A DNAI4 TEKT1 TMEM231 CFAP44 DNAH9	9.78e-07	197	171	8	d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CRYBG2 EPS8L2 MYO6 FCGBP TMPRSS11D TTC9 PARD3 TACSTD2	1.02e-06	198	171	8	72d91bd0c727ecadc41e023a16c9326158db1b7b
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CRYBG2 EPS8L2 MYO6 FCGBP TMPRSS11D TTC9 PARD3 TACSTD2	1.02e-06	198	171	8	441608034c787e55691558a480dcd07e37419138
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL12A1 BIRC6 BMPR2 AHR ADGRL2 UTRN FAM135A ADGRL3	1.10e-06	200	171	8	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Biopsy_Other_PF-Epithelial-Differentiating_Ciliated\|Biopsy_Other_PF / Sample group, Lineage and Cell type	PTPRT PROM1 NEK5 DNAI4 TEKT1 TMEM231 CFAP44 DNAH9	1.10e-06	200	171	8	f7b4581d958afbd68f9045af619aaca0ab463439
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TET2 EPSTI1 MED13L BIRC6 CELF2 HELZ UTRN GOLGB1	1.10e-06	200	171	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	severe_COVID-19-pDC\|World / disease group, cell group and cell class (v2)	LGMN TTC28 LRGUK PPP2R3A FBXO24 SFXN2 TMEM231	2.78e-06	159	171	7	e1c48c4ceda116826819ff9adeed7bad6a58844d
ToppCell	severe_COVID-19-pDC\|severe_COVID-19 / disease group, cell group and cell class (v2)	LGMN TTC28 LRGUK PPP2R3A FBXO24 SFXN2 TMEM231	2.78e-06	159	171	7	ea5088d27e42b8850455764d53b757ea8d8f14bc
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 FAT3 PTPRT KIAA1549L AADACL2 DNAH9 SPESP1	2.90e-06	160	171	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 FAT3 PTPRT KIAA1549L AADACL2 DNAH9 SPESP1	2.90e-06	160	171	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th\|T/NK_cells / Location, Cell class and cell subclass	ZNF410 CRYBG2 TAB2 CREG1 APPL2 ARHGEF6 KIF1C	4.85e-06	173	171	7	42c911ed16fabdabef063830e8407192d8bde950
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PROM1 MYO3A NEK5 DNAI4 TMEM231 CFAP44 DNAH9	4.85e-06	173	171	7	c3762655caa79ac4879876f470d32578a3c93b01
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GRID1 LGR5 TFR2 TMTC1 BMPR2 UTRN ADGRL3	5.23e-06	175	171	7	316f2ea930437bf1243b1c0f45e6bd864112c6f2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GRID1 LGR5 TFR2 TMTC1 BMPR2 UTRN ADGRL3	5.23e-06	175	171	7	a9f08e1e4c2997dcdd3e5d92daac480da19100b8
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTPRT LRGUK NEK5 LRRC53 DNAI4 CFAP44 DNAH9	5.43e-06	176	171	7	dee780cfa85234a7cd7bf440b66b84cec959893e
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PROM1 NEK5 CC2D2A DNAI4 TMEM231 CFAP44 DNAH9	6.30e-06	180	171	7	1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KNTC1 ATAD5 WDR76 DSN1 MYO3A ESPL1 KNL1	6.30e-06	180	171	7	f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(other)\|COVID-19 / group, cell type (main and fine annotations)	ANO2 TMTC1 HECW2 TMEM145 SEMA6A ADGRL2 ADGRL3	6.53e-06	181	171	7	26eb4ee57a70dbf54e096b73129fda9dfda1f6ec
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SPAG1 PTPRT LRGUK DNAI4 TEKT1 TMEM231 DNAH9	6.53e-06	181	171	7	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO6 LGR5 BMPR2 HECW2 SEMA6A ADGRL2 ADGRL3	6.77e-06	182	171	7	a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50
ToppCell	Ciliated_cells-B-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	CCDC148 NEK5 DNAI4 TEKT1 TMEM231 CFAP44 DNAH9	6.77e-06	182	171	7	e93968f800bfeb258e4e834fc8bf92d1cb72cd73
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA ANO2 COL12A1 FAT3 GRID1 DNAH9 ADGRL3	7.27e-06	184	171	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA ANO2 COL12A1 FAT3 GRID1 DNAH9 ADGRL3	7.27e-06	184	171	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA ANO2 COL12A1 FAT3 GRID1 DNAH9 ADGRL3	7.27e-06	184	171	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LRGUK NEK5 CC2D2A DNAI4 TMEM231 CFAP44 DNAH9	7.53e-06	185	171	7	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	PTPRT LRGUK NEK5 DNAI4 TEKT1 TMEM231 DNAH9	7.53e-06	185	171	7	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL12A1 PDGFRL GRID1 PTPRT MYOZ1 TMEM145 ALPL	7.80e-06	186	171	7	4e983de6d2515082f9e555f4f949cec84281c140
ToppCell	Ciliated_cells-B-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	PTPRT PROM1 NEK5 DNAI4 TEKT1 TMEM231 DNAH9	7.80e-06	186	171	7	f72267d533fd0c5280d9741ceee3dd116300a7e4
ToppCell	Control-Endothelial_cells-Endothelial_cells_(other)\|Control / group, cell type (main and fine annotations)	ANO2 TTC28 TMTC1 BMPR2 HECW2 SEMA6A ADGRL2	7.80e-06	186	171	7	c6075fe84226b370c5139066793844ad33ae2db1
ToppCell	COPD-Epithelial-Ciliated\|COPD / Disease state, Lineage and Cell class	PTPRT PROM1 NEK5 AADACL2 DNAI4 TEKT1 DNAH9	8.08e-06	187	171	7	f0fd0792f6926f705d175f6e6fd480f12c7a3bd4
ToppCell	Control-Endothelial_cells-Endothelial_cells_(general)\|Control / group, cell type (main and fine annotations)	ANO2 TTC28 TMTC1 BMPR2 HECW2 SEMA6A ADGRL2	8.08e-06	187	171	7	fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8
ToppCell	21-Trachea-Epithelial-Intermediate_ciliated\|Trachea / Age, Tissue, Lineage and Cell class	PTPRT CC2D2A DNAI4 TEKT1 TMEM231 CFAP44 DNAH9	8.08e-06	187	171	7	1a2178a195d078d1963947b327c6d0d4f2f48341
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KNTC1 ATAD5 WDR76 FCGBP PIK3CD ESPL1 KNL1	8.08e-06	187	171	7	73931a5ea73799095daff100b5f18853c57c74dc
ToppCell	Ciliated_cells-B-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	PTPRT PROM1 NEK5 DNAI4 TEKT1 TMEM231 DNAH9	8.08e-06	187	171	7	bc1f33f332ac939c2425f510173430ca2ba0c3ee
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANO2 TTC28 BMPR2 HECW2 SEMA6A ADGRL2 ADGRL3	8.36e-06	188	171	7	117dc80fa940e6aa1b0187a43fdde33f3fcb578f
ToppCell	Epithelial-Epithelial-D_(Ciliated)\|Epithelial / shred on cell class and cell subclass (v4)	CEP290 IFT88 NEK5 DNAI4 TEKT1 CFAP44 DNAH9	8.36e-06	188	171	7	8f30535a32968a81a304315a49c0d90a77d36948
ToppCell	Adult-Epithelial-ciliated_cell-D231\|Adult / Lineage, Cell type, age group and donor	PTPRT CCDC148 LRGUK NEK5 DNAI4 TEKT1 DNAH9	8.36e-06	188	171	7	34b11f72ca73153d02edcd09b38983ad1a504659
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EPS8L2 COL12A1 MYO6 TKT PARD3 TACSTD2 FAM135A	8.36e-06	188	171	7	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRT ZNF462 PROM1 SLC44A5 PARD3 UTRN ADGRL3	8.36e-06	188	171	7	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL12A1 MYO6 FAT3 CDC42EP1 YAP1 PAPPA ALPL	8.36e-06	188	171	7	de6f4889e0c5f39fbbaefd85526f645c6afa09d5
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PTPRT LRGUK NEK5 DNAI4 TEKT1 TMEM231 DNAH9	8.36e-06	188	171	7	2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCell	Control-Endothelial_cells\|Control / group, cell type (main and fine annotations)	ANO2 TTC28 TMTC1 BMPR2 HECW2 SEMA6A ADGRL2	8.36e-06	188	171	7	3953b08abfea93468fc8d177bdb16ca7c6ffa1ab
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PTPRT LRGUK NEK5 DNAI4 TEKT1 TMEM231 DNAH9	8.66e-06	189	171	7	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	PTPRT PROM1 NEK5 DNAI4 TEKT1 TMEM231 DNAH9	8.66e-06	189	171	7	dc440015949a768188c67661b6be63b1ead1a0f0
ToppCell	wk_20-22-Hematologic-Myeloid-APOE+_Mac2\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	OTOA LGMN ACP2 CREG1 SIGLEC15 FCGBP UPP1	8.66e-06	189	171	7	e189ef6066f87177d758f0e3ed9a17e01031a391
ToppCell	Adult-Epithelial-ciliated_cell\|Adult / Lineage, Cell type, age group and donor	PTPRT CCDC148 LRGUK NEK5 DNAI4 TEKT1 DNAH9	8.66e-06	189	171	7	b679920f0993e917dd86da082113bfbd85ea1ca5
ToppCell	Ciliated_cells-B\|World / lung cells shred on cell class, cell subclass, sample id	PTPRT PROM1 NEK5 DNAI4 TEKT1 TMEM231 DNAH9	8.96e-06	190	171	7	7031fbedc13be1a00f6333ad6d51849c3739c2e6
ToppCell	10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	LGMN COL12A1 PDGFRL FAT3 CDC42EP1 FCGBP ALPL	8.96e-06	190	171	7	cf463b2f227f3cc7d3fd296c810c0cbe51cbee72
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3B MYO6 BMPR2 HECW2 SEMA6A ADGRL2 ADGRL3	8.96e-06	190	171	7	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO6 LGR5 BMPR2 HECW2 SEMA6A ADGRL2 ADGRL3	8.96e-06	190	171	7	0a351609a72fd638c84b2435782e312ee6a33aac
Disease	Arima syndrome	CEP290 CC2D2A TMEM231	6.02e-06	7	166	3	C1855675
Disease	ciliopathy (implicated_via_orthology)	CEP290 CC2D2A DNAI4 TEKT1	7.54e-05	40	166	4	DOID:0060340 (implicated_via_orthology)
Disease	Meckel-Gruber syndrome	CEP290 CC2D2A TMEM231	7.57e-05	15	166	3	C0265215
Disease	reaction time measurement	GPR155 TET2 BNC2 TTC28 MED13L KIAA1549L CCAR1 SFXN2 CC2D2A DNAI4 ADGRL2 METTL15 RAI1	9.58e-05	658	166	13	EFO_0008393
Disease	Meckel syndrome type 1	CEP290 CC2D2A TMEM231	1.34e-04	18	166	3	C3714506
Disease	cholesteryl esters to total lipids in small VLDL percentage	TDRD15 CELSR2 SEC16A ABCG8	1.68e-04	49	166	4	EFO_0022256
Disease	Familial aplasia of the vermis	CEP290 CC2D2A TMEM231	1.86e-04	20	166	3	cv:C0431399
Disease	Antithrombotic agent use measurement	TDRD15 APOA4 CELSR2 ABCG8	2.63e-04	55	166	4	EFO_0009925
Disease	Alzheimer disease, whole-brain volume	SLC44A5 YAP1	3.11e-04	5	166	2	EFO_0005089, MONDO_0004975
Disease	p-tau measurement, cerebrospinal fluid biomarker measurement	TTC28 ADGRL2	3.11e-04	5	166	2	EFO_0004763, EFO_0006794
Disease	biological sex	ZNF280D TTC28 FAT3 FBXL4 SEMA6A PARD3 NUP160	3.39e-04	230	166	7	PATO_0000047
Disease	cancer	TET2 BNC2 TTC28 ATAD5 LMTK2 TAB2 CELF2 AHR PARD3	4.61e-04	400	166	9	MONDO_0004992
Disease	Polydactyly	CEP290 PROM1 IFT88 CC2D2A TMEM231	5.35e-04	117	166	5	C0152427
Disease	age at menarche	TET2 MTIF3 TTC28 MYO6 FNDC3A ZNF462 CELF1 LRRC53 TNRC6A ADGRL2 METTL15	5.70e-04	594	166	11	EFO_0004703
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	TET2 BNC2 TTC28 BIRC6 LRGUK BMPR2 CELF2 TNRC6A HELZ ADGRL2 METTL15 UTRN ADGRL3	6.32e-04	801	166	13	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	cutaneous squamous cell carcinoma	BNC2 SEC16A AHR	8.43e-04	33	166	3	EFO_1001927
Disease	esterified cholesterol measurement, intermediate density lipoprotein measurement	TDRD15 CELSR2	8.61e-04	8	166	2	EFO_0008589, EFO_0008595
Disease	Hereditary spherocytosis	CAD EPB42	8.61e-04	8	166	2	C0037889
Disease	Meckel syndrome (implicated_via_orthology)	CC2D2A TMEM231	8.61e-04	8	166	2	DOID:0050778 (implicated_via_orthology)
Disease	metabolic syndrome	APOA4 PPP2R3A CELSR2 CELF1 TNRC6A ABCG8	9.72e-04	200	166	6	EFO_0000195
Disease	gut microbiome measurement, bone density	COL12A1 GRID1 SLC44A5 ADGRL2	9.97e-04	78	166	4	EFO_0003923, EFO_0007874
Disease	protein CREG1 measurement	LGMN CREG1	1.10e-03	9	166	2	EFO_0801937
Disease	Nonsyndromic Deafness	OTOA EPS8L2 MYO6 MYO3A	1.15e-03	81	166	4	C3711374
Disease	free cholesterol to total lipids in large VLDL percentage	TDRD15 CELSR2 SEC16A	1.18e-03	37	166	3	EFO_0022281
Disease	breast cancer, ovarian carcinoma	BNC2 TTC28 CCDC88C	1.18e-03	37	166	3	EFO_0001075, MONDO_0007254
Disease	lipoprotein measurement, phospholipid measurement	TDRD15 CELSR2 CELF1 ABCG8	1.37e-03	85	166	4	EFO_0004639, EFO_0004732
Disease	Meckel-Gruber syndrome	CEP290 CC2D2A	1.37e-03	10	166	2	cv:C0265215
Disease	cholesterol in very small VLDL measurement	TDRD15 CELSR2 ABCG8	1.48e-03	40	166	3	EFO_0022231
Disease	free cholesterol in medium LDL measurement	TDRD15 CELSR2 ABCG8	1.48e-03	40	166	3	EFO_0022268
Disease	concentration of large LDL particles measurement	TDRD15 CELSR2 ABCG8	1.96e-03	44	166	3	EFO_0022160
Disease	coffee consumption measurement, tea consumption measurement	TET2 AHR NUP160	1.96e-03	44	166	3	EFO_0006781, EFO_0010091
Disease	cholesterol in medium VLDL measurement	TDRD15 CELSR2 ABCG8	1.96e-03	44	166	3	EFO_0022225
Disease	Cooley's anemia	CAD TFR2	2.00e-03	12	166	2	C0002875
Disease	Thalassemia Intermedia	CAD TFR2	2.00e-03	12	166	2	C0271979
Disease	Abruptio Placentae	TDRD15 PDGFRL	2.00e-03	12	166	2	EFO_1001754
Disease	Thalassemia Minor	CAD TFR2	2.00e-03	12	166	2	C0085578
Disease	beta Thalassemia	CAD TFR2	2.00e-03	12	166	2	C0005283
Disease	cholesterol to total lipids in large VLDL percentage	TDRD15 CELSR2 ABCG8	2.09e-03	45	166	3	EFO_0022236
Disease	pulse pressure measurement	TET2 TDRD15 BNC2 PCBP3 TTC28 FAT3 MED13L ARHGEF25 CWC22 PROM1 KIAA1549L CELF1 CELF2 YAP1 TNRC6A DCLRE1A NUP160	2.26e-03	1392	166	17	EFO_0005763
Disease	Gastrointestinal Stromal Sarcoma	IFT88 CC2D2A TMEM231	2.36e-03	47	166	3	C3179349
Disease	free cholesterol in very small VLDL measurement	TDRD15 CELSR2 ABCG8	2.36e-03	47	166	3	EFO_0022275
Disease	total cholesterol measurement, intermediate density lipoprotein measurement	TDRD15 TFR2 CELSR2 ABCG8	2.40e-03	99	166	4	EFO_0004574, EFO_0008595
Disease	non-high density lipoprotein cholesterol measurement	TDRD15 BNC2 PDE3B NTSR1 BMPR2 APPL2 CELSR2 AHR HELZ ABCG8 RAI1	2.44e-03	713	166	11	EFO_0005689
Disease	total lipids in lipoprotein particles measurement	TDRD15 CELSR2 ABCG8	2.51e-03	48	166	3	EFO_0022309
Disease	phospholipids in medium LDL measurement	TDRD15 CELSR2 ABCG8	2.66e-03	49	166	3	EFO_0022183
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	TDRD15 CELSR2	2.74e-03	14	166	2	EFO_0004611, EFO_0008589
Disease	urate measurement, bone density	PDE3B TTC28 GRID1 FBXL4 YAP1 SEC16A KAT6B DNAH9 UTRN FAM135A	2.75e-03	619	166	10	EFO_0003923, EFO_0004531
Disease	Gastrointestinal Stromal Tumors	IFT88 CC2D2A TMEM231	2.82e-03	50	166	3	C0238198
Disease	free cholesterol in LDL measurement	TDRD15 CELSR2 ABCG8	2.82e-03	50	166	3	EFO_0022266
Disease	free cholesterol measurement, intermediate density lipoprotein measurement	TDRD15 TFR2 CELSR2 ABCG8	2.87e-03	104	166	4	EFO_0008591, EFO_0008595
Disease	neuroimaging measurement	ANO2 FAT3 KLHL20 ZNF462 CCDC88C CELF1 TNRC6A NIPAL2 CC2D2A PAPPA QSER1 CDC5L PARD3 RAI1	2.97e-03	1069	166	14	EFO_0004346
Disease	free cholesterol in large LDL measurement	TDRD15 CELSR2 ABCG8	2.99e-03	51	166	3	EFO_0022176
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	OTOA MYO6 MYO3A	2.99e-03	51	166	3	cv:CN043650
Disease	cholesterol to total lipids in small VLDL percentage	TDRD15 CELSR2 ABCG8	2.99e-03	51	166	3	EFO_0022242
Disease	mortality	PDE3B TTC28 CCDC148 SVIL PAPPA	3.03e-03	173	166	5	EFO_0004352
Disease	blood phosphate measurement	PPP2R3A CDC5L GOLGB1 ALPL KNL1	3.10e-03	174	166	5	EFO_0010972
Disease	response to statin, LDL cholesterol change measurement	TDRD15 CELSR2	3.15e-03	15	166	2	EFO_0007804, GO_0036273
Disease	Hemoglobin F Disease	CAD TFR2	3.15e-03	15	166	2	C0019025
Disease	phospholipids in IDL measurement	TDRD15 CELSR2 ABCG8	3.16e-03	52	166	3	EFO_0022164
Disease	total lipids in LDL measurement	TDRD15 CELSR2 ABCG8	3.16e-03	52	166	3	EFO_0022308
Disease	phospholipids in large LDL measurement	TDRD15 CELSR2 ABCG8	3.33e-03	53	166	3	EFO_0022174
Disease	total phospholipids in lipoprotein particles measurement	TDRD15 CELSR2 ABCG8	3.33e-03	53	166	3	EFO_0022315
Disease	free cholesterol in small LDL measurement	TDRD15 CELSR2 ABCG8	3.33e-03	53	166	3	EFO_0022271
Disease	total lipids in medium VLDL	TDRD15 CELSR2 ABCG8	3.51e-03	54	166	3	EFO_0022153
Disease	Hepatomegaly	GPR155 COPS3 AHR	3.51e-03	54	166	3	C0019209
Disease	Stevens-Johnson syndrome, toxic epidermal necrolysis, response to anticonvulsant	TAB2 NIPAL2	3.58e-03	16	166	2	EFO_0004276, EFO_0004775, GO_0036277
Disease	coffee consumption measurement	TET2 APOA4 BIRC6 AHR RAI1	3.76e-03	182	166	5	EFO_0006781
Disease	free cholesterol measurement	TDRD15 CELSR2 NUP160 ABCG8	3.87e-03	113	166	4	EFO_0008591
Disease	cholesterol to total lipids in large LDL percentage	TDRD15 CELSR2 ABCG8	3.90e-03	56	166	3	EFO_0022235
Disease	free cholesterol to total lipids in large HDL percentage	TDRD15 CELSR2 ABCG8	3.90e-03	56	166	3	EFO_0022279
Disease	cortical surface area measurement	TET2 BNC2 ANO2 FAT3 MED13L CCDC88C CELF2 PIK3CD TNRC6A CCAR1 PAPPA SEMA6A QSER1 CDC5L PARD3 ADGRL2	3.92e-03	1345	166	16	EFO_0010736
Disease	low density lipoprotein cholesterol measurement, lipid measurement	TDRD15 TFR2 CELSR2 ABCG8	3.99e-03	114	166	4	EFO_0004529, EFO_0004611
Disease	total cholesterol measurement, low density lipoprotein cholesterol measurement	TDRD15 TFR2 CELSR2 ABCG8	3.99e-03	114	166	4	EFO_0004574, EFO_0004611
Disease	uridine diphosphate galactose measurement, uridine diphosphate glucose measurement	EOGT SVIL	4.05e-03	17	166	2	EFO_0010543, EFO_0010544
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	TDRD15 CELSR2	4.05e-03	17	166	2	EFO_0022232
Disease	total lipids in large LDL	TDRD15 CELSR2 ABCG8	4.10e-03	57	166	3	EFO_0022163
Disease	cholesterol in large LDL measurement	TDRD15 CELSR2 ABCG8	4.10e-03	57	166	3	EFO_0021901
Disease	free cholesterol to total lipids in medium VLDL percentage	TDRD15 CELSR2 ABCG8	4.10e-03	57	166	3	EFO_0022284
Disease	antihyperlipidemic drug use measurement	BNC2 COPS3 CELSR2 ABCG8	4.12e-03	115	166	4	EFO_0803367
Disease	neuroblastoma	TDRD15 LRRC45 GRID1 CEP295	4.24e-03	116	166	4	EFO_0000621
Disease	triglycerides to total lipids in small VLDL percentage	TDRD15 CELSR2 ABCG8	4.30e-03	58	166	3	EFO_0022338
Disease	cholesterol in IDL measurement	TDRD15 CELSR2 ABCG8	4.30e-03	58	166	3	EFO_0021899
Disease	phospholipids in LDL measurement	TDRD15 CELSR2 ABCG8	4.30e-03	58	166	3	EFO_0022294
Disease	HMG CoA reductase inhibitor use measurement	TDRD15 APOA4 BMPR2 CELSR2 ABCG8	4.41e-03	189	166	5	EFO_0009932
Disease	phospholipids in VLDL measurement	TDRD15 CELSR2 ABCG8	4.51e-03	59	166	3	EFO_0022301
Disease	phospholipids in small LDL measurement	TDRD15 CELSR2 ABCG8	4.51e-03	59	166	3	EFO_0022297
Disease	very low density lipoprotein cholesterol measurement, esterified cholesterol measurement	TDRD15 CELSR2	4.54e-03	18	166	2	EFO_0008317, EFO_0008589
Disease	Hypercholesterolemia, Familial	APOA4 ABCG8	4.54e-03	18	166	2	C0020445
Disease	birth weight, parental genotype effect measurement	TET2 USF3 CELF2 YAP1 RAI1	4.71e-03	192	166	5	EFO_0004344, EFO_0005939
Disease	total lipids in IDL	TDRD15 CELSR2 ABCG8	4.73e-03	60	166	3	EFO_0022161
Disease	low density lipoprotein cholesterol measurement, phospholipid measurement	TDRD15 TFR2 CELSR2 ABCG8	4.79e-03	120	166	4	EFO_0004611, EFO_0004639
Disease	cutaneous melanoma	BNC2 MED13L AHR PARD3	4.93e-03	121	166	4	EFO_0000389
Disease	free cholesterol in IDL measurement	TDRD15 CELSR2 ABCG8	4.96e-03	61	166	3	EFO_0022181
Disease	free cholesterol in VLDL measurement	TDRD15 CELSR2 ABCG8	4.96e-03	61	166	3	EFO_0022276
Disease	alkaline phosphatase measurement	TET2 TDRD15 PTPN22 TULP2 MYO3A YAP1 TEKT1 CDC5L UTRN NUP160 GOLGB1 RAI1 ALPL	5.00e-03	1015	166	13	EFO_0004533
Disease	Hypertriglyceridemia	TDRD15 APOA4	5.05e-03	19	166	2	EFO_0004211
Disease	emphysema pattern measurement	SVIL SOWAHB	5.05e-03	19	166	2	EFO_0005850
Disease	SARS-CoV-2 antibody measurement, response to COVID-19 vaccine	TAB2 MED13L TDRD3	5.19e-03	62	166	3	EFO_0803360, EFO_0803362
Disease	coronary artery disease, plasminogen activator inhibitor 1 measurement	TDRD15 CELSR2 ABCG8	5.42e-03	63	166	3	EFO_0001645, EFO_0004792
Disease	freckles	BNC2 PARD3	5.59e-03	20	166	2	EFO_0003963

Protein segments in the cluster

Peptide	Gene	Start	Entry
AISNILNRVNPSSYS	ZNF280D	56	Q6N043
PSDYQQQQSLALNSS	AHR	596	P35869
PTNDLTFYVSQKRNN	ATAD5	1741	Q96QE3
LQSYTQLNFRPIEDA	EOGT	211	Q5NDL2
RPLRTSQIYAQDENA	EP400	2441	Q96L91
YQPLTASVSLQNSLD	EPB42	601	P16452
LANDSQLQNLPLTYI	AADACL2	321	Q6P093
AALPTLYSQSLLQQQ	CELF2	396	O95319
YNVTNNSVALRTPRT	CDC5L	341	Q99459
LNTYNEQQIISDPRL	CCDC148	536	Q8NFR7
QSLLVTYLRPLQSNN	ARHGEF6	261	Q15052
TYLRPLQSNNNLSTV	ARHGEF6	266	Q15052
IQRYVLQAADPAISQ	ARHGEF25	441	Q86VW2
QSPIEYQRRESQTNS	ARHGEF25	476	Q86VW2
YNANRIPVISLNQAS	BIRC6	2686	Q9NR09
VYSTNNPSELRNLVN	COPS3	266	Q9UNS2
YKNDQTPNRNALTSI	BNC2	376	Q6ZN30
QTPANYQLTQTAALQ	CCAR1	56	Q8IX12
AAALPTLYNQNLLTQ	CELF1	371	Q92879
IPSYLNNHERSSEQN	ADGRL3	1246	Q9HAR2
SGQPNTLEVRDLNYQ	ABCG8	41	Q9H221
YTPASRSENQDSLQA	ANKIB1	831	Q9P2G1
DFQNSRQTTTYKLPN	ADGRL2	191	O95490
TSVNNAYTPQLSLLQ	DOP1A	1406	Q5JWR5
NNPTFTQPEYTVRLN	CELSR2	606	Q9HCU4
RSSSVINNYLDANEP	ANO2	66	Q9NQ90
RVYVLNQNDPSLTSL	CFAP44	831	Q96MT7
SQETSRLENYRQPSQ	RAI1	21	Q7Z5J4
TNENYPAQTRDLSSV	QSER1	406	Q2KHR3
RTQRPSLVQTQEQYE	PTPN22	266	Q9Y2R2
SLQNYTRADQSPQIA	KAT6B	1571	Q8WYB5
EPYADQLRTQVSTQA	APOA4	136	P06727
YTLSPENLQSLAAQS	HECW2	21	Q9P2P5
AVSQYVSDLSPAQQQ	OTOA	491	Q7RTW8
SAYLAIRTAQIQDNP	HCFC2	711	Q9Y5Z7
NFLDYISSNNRQTLP	MED13L	1241	Q71F56
LNDLDRISQSNYIPT	GNAI3	156	P08754
RISQSNYIPTQQDVL	GNAI3	161	P08754
SSTINPILYNLVSAN	NTSR1	356	P30989
VNTRFLLYTNENPNN	PNLIP	51	P16233
SPPAINANTLQQERY	GPR155	841	Q7Z3F1
SELNQFSLSPRNQTQ	LRRC53	916	A6NM62
AQRPSASDLQLQLTY	LMTK3	396	Q96Q04
RRENLNSYQRNSSPE	CWC22	16	Q9HCG8
YQSVSAENLRLQQSL	CCDC88C	761	Q9P219
QRRTSAYTLIAPNIN	EPSTI1	61	Q96J88
VRYNVINALPNTADS	FAM135A	1471	Q9P2D6
LVQRNTSTEPAEYQL	MTIF3	116	Q9H2K0
TPDFYQQLRNSDSNL	PDE3B	561	Q13370
TNAPQAVLYNDRSVL	PDE3B	836	Q13370
SAEPNYNQRQELRSN	NEK5	431	Q6P3R8
STEDPQFASQQQVYR	KIF1C	61	O43896
PRNLLANQTLVYSQD	KNL1	1421	Q8NG31
LYEHPSINQRIQNSS	KNTC1	1776	P50748
AAQPYSNLSNLDVLN	LMTK2	346	Q8IWU2
QNAVLAYVQASPVRT	LRRC45	651	Q96CN5
RESLYQLLSQTSPEN	MICAL1	436	Q8TDZ2
PVSVTQLDQSALNYS	KIAA1549L	1691	Q6ZVL6
VQLYSRTQDVSPQAL	LCN15	136	Q6UWW0
PYLLELNASQNNLTT	LRGUK	171	Q96M69
EVIASYNQLSSFRQP	PAPPA	336	Q13219
QARSIYPITRTQQLA	METTL15	241	A6NJ78
NPLIYSLRNNDVNVA	OR8J3	286	Q8NGG0
SNIFVYVRPNQNSSL	OR6M1	251	Q8NGM8
KRQAVTNPNNTFYAT	HSPA9	106	P38646
RYQIPLSADQLFTQS	HELZ	431	P42694
VQSIPNNSTNSLYNL	PPP2R3A	366	Q06190
QRSQTVLNQLRYPSV	EPS8L2	121	Q9H6S3
TPANISLAQYLINAR	PCBP3	346	P57721
YNISRLDPQTNSSQI	PTPRT	1161	O14522
NDNSPAFDQSTYRVQ	PCDHAC2	251	Q9Y5I4
QNETRQTPEYQNESS	ACP2	166	P11117
QTPEYQNESSRNAQF	ACP2	171	P11117
QYELNRNNVTDPSLS	ALPL	296	P05186
ELIVNYRAQASQATP	GALM	156	Q96C23
YRAQASQATPVNLTN	GALM	161	Q96C23
LQQYQVALSASPLTS	CHD9	2016	Q3L8U1
QLVAAYLSLPSNNLS	ESPL1	906	Q14674
AVNSDRYNPAALTNK	IFT88	476	Q13099
TSPLNTVERYNPQEN	KLHL20	471	Q9Y2M5
VYPNNLQATAELVAR	CC2D2A	1316	Q9P2K1
PRNLQVYNATSNSLT	COL12A1	1756	Q99715
PSSASIINSQNEYLI	CEP290	771	O15078
PQSLATLYQLVSQAS	COL20A1	1191	Q9P218
NSQTSPLNAEVVQYA	FBXL4	41	Q9UKA2
QPYNVAQLQSSVDLS	FCGBP	196	Q9Y6R7
NNLQPDTTYRIRIQA	FNDC3A	916	Q9Y2H6
SRDIYNLQQPEDSQS	CRYBG2	1186	Q8N1P7
SPQEQSASYQDRRQS	DSN1	81	Q9H410
QPLDREQQSSYNISV	FAT3	3191	Q8TDW7
SINYERQQAQARIPS	BMPR2	586	Q13873
SLPQLNQAAYDSLVV	CDC42EP1	121	Q00587
NNISRQIYLTDNPEA	APPL2	371	Q8NEU8
SLVVNETQLDQPRSY	FBXO24	271	O75426
ETQLDQPRSYTVQLA	FBXO24	276	O75426
EFSQVNNPLISRLYD	COQ5	246	Q5HYK3
IAIYNVRSNSNVPVL	DNAI4	561	Q5VTH9
TQTLEPTREYQNTQL	GRID1	911	Q9ULK0
QQYTNLQERPSSVLT	SLC44A5	291	Q8NCS7
NTQQSPVAATLYVRN	SPAM1	266	P38567
YRFNSLNDLSQPISQ	DCLRE1A	376	Q6PJP8
QQASNYLSPEDLLRS	DNAH9	371	Q9NYC9
YLSPLQLSVSNLQEN	CREG1	106	O75629
QLSVSNLQENPYATL	CREG1	111	O75629
VPSTQDIYQRQNSSD	CEP295	2011	Q9C0D2
RLQPSQLSSNLYNKQ	SACS	276	Q9NZJ4
AISQPDAQRYVNTLL	IPO13	266	O94829
SVNQNNYSRNPTQSL	FAM171B	471	Q6P995
TLSDQNNQRVPQYRA	GARNL3	126	Q5VVW2
LNYNNLDEFPTAIRT	LGR5	241	O75473
RESSQQAQRQYSSLP	PARD3	1211	Q8TEW0
YLTALQISNPANDAQ	RTL4	81	Q6ZR62
NVLSEYQQRPQRLVS	UPP1	286	Q16831
RQTTRPYSQVNVLNF	UTRN	161	P46939
PRSQAQESNYENLSQ	SIGLEC15	301	Q6ZMC9
NYTNRNAASPTSVRQ	SFXN2	131	Q96NB2
NVNTDYQNPVRSNSF	TDRD3	476	Q9H7E2
AADRYLLSQSSQPQS	TBR1	101	Q16650
VNLTEQNSNNSAVPY	SVIL	1426	O95425
NSQTLNRNQPTVYIA	TAB2	356	Q9NYJ8
ALNQTTSQNPYDLIR	TDRD15	1266	B5MCY1
PVTNLRNLDLSYNQL	LRRTM3	131	Q86VH5
SNEPSVRQQLLQGYD	NDUFAF7	376	Q7L592
QQYQQFLDASRSLPD	RFX1	571	P22670
YEQPTIQIELRQNTS	TACSTD2	196	P09758
APNITQAISARTVQY	NIPAL2	161	Q9H841
YQSLNDIPDRVQRQT	PROM1	361	O43490
LNNNSPNIRYSENAV	TEKT1	191	Q969V4
PTQLRPNYQLNSSRN	SPATA31D4	436	Q6ZUB0
PQVQSAAIRIQASYR	SPEGNB	26	A0A087WV53
QVQQALLSDTSNPAY	SPESP1	236	Q6UW49
NDQFIQISTRLPSEY	SI	1096	P14410
QRIDNFSVVSYLLNP	PPP1R15B	211	Q5SWA1
QNERYGQLTLVNSTS	PDGFRL	121	Q15198
QAYEALTQIPDSSRQ	NUP160	1016	Q12769
NTIAVTQTLPNAAYN	OLFM4	356	Q6UX06
PSSLHYSTLQQQQQR	SOWAHB	291	A6NEL2
YSARNLNPLSSEQEI	SIX6OS1	506	Q8N1H7
AYPELQRNSAQIANL	AARS2	386	Q5JTZ9
YSQAEAQPLLTTLQA	PLAGL2	441	Q9UPG8
YSPSTVILDERQTNN	SPATA1	146	Q5VX52
NNLQYVAISNLPAAT	SLC35A2	126	P78381
RNETLSNRYLQPTQV	TNFRSF10D	276	Q9UBN6
SNRYLQPTQVSEQEI	TNFRSF10D	281	Q9UBN6
RQFPNYSSELNVNAL	TRBV5-8	86	A0A5A2
LLNVEYNSQLNSPAT	TMPRSS11D	56	O60235
RQFPNYSSELNVNAL	TRBV5-5	86	A0A597
PTQLRPNYQLNSSRN	SPATA31D3	436	P0C874
PEQASVTNQNEYARS	ZDHHC20	301	Q5W0Z9
VQPLNEQESLLSRYQ	TULP2	421	O00295
SYRVAVQLNPDQAQA	TMTC1	811	Q8IUR5
RTSRPENAIIYNNNE	TKT	471	P29401
FTLSRTLENPVNVYN	SEC16A	996	O15027
VTVSRQPSLNAYNSL	SEMA6A	981	Q9H2E6
RQSYEVSVLTAVNPQ	ZNF410	451	Q86VK4
ISALPTVVAYNNRAQ	SPAG1	236	Q07617
QSTLPSQQNRFPDYL	YAP1	431	P46937
YLNFPVSRNANLSTI	PIK3CD	31	O00329
SRYVATDINLNNSFP	USF3	471	Q68DE3
QNLSQTQRSPHIFYR	USP9Y	586	O00507
PSQTLNDREYQLLRQ	CAD	636	P27708
IISNEPLATYQENRN	TTC28	2061	Q96AY4
ENQNIAYVSLRPAQT	WDR76	26	Q9H967
AYQERNVTTVLNDPN	TMEM231	216	Q9H6L2
EPIITLYNRNNATEN	ZNF484	186	Q5JVG2
QVSNTALLNTQTPIY	ZNF462	811	Q96JM2
AYLNSPSLNFVTDNQ	ZNF148	621	Q9UQR1
QQVVSENANYLRTPR	PPIP5K2	1031	O43314
LEEVQNINRRNSPYS	TET2	806	Q6N021
AQQLSPRSSQTVYQR	TFR2	11	Q9UP52
ASLAYRTQNTAASQP	nan	156	Q96M66
RTVQLNVSYAPQNLA	SIGLEC14	226	Q08ET2
IRASNYNVPLSSTAQ	TNRC6A	1676	Q8NDV7
AQLYSAAPSNSLIRN	TRPM4	461	Q8TD43
RPENNQVINLTTQYA	TMEM145	101	Q8NBT3
RTQQPTDTNVIRYIQ	TTC9	191	Q92623
SQTQPLKVQYQRQAS	GOLGB1	2996	Q14789
NINVYATTAANPRES	LGMN	201	Q99538
QLYVSQNAIERISPD	LRIG2	291	O94898
PQAANDQLTVLSIYT	ART3	191	Q13508
TNAVESNNRVYQTPK	MYO3A	1176	Q8NEV4
EPTLSQRSIYQNANS	MYO3A	1286	Q8NEV4
LQNAIESRQARPTYA	MYO6	1271	Q9UM54
LSEPLVLYNQNLSNR	MYOZ1	251	Q9NP98